ELISA ENO1 anti-

Quantity :50µL Clone Number: Aliases:2 phospho D glycerate hydro lyase antibody; 2-phospho-D-glycerate hydro-lyase antibody; Alpha enolase antibody; Alpha enolase like 1 antibody; Alpha-enolase antibody; C myc promoter binding protein antibody; C-myc promoter-binding protein antibody; EC 4.2.1.11 antibody; eno1 antibody; ENO1L1 antibody; ENOA_ antibody; Enolase 1 (alpha) antibody; Enolase 1 (alpha) like 1 antibody; Enolase 1 antibody; Enolase alpha antibody; MBP 1 antibody; MBP-1 antibody; MBP1 antibody; MBPB1 antibody; MPB 1 antibody; MPB-1 antibody; MPB1 antibody; MYC promoter binding protein 1 antibody; NNE antibody; Non neural enolase antibody; Non-neural enolase antibody; Phosphopyruvate hydratase antibody; Plasminogen binding protein antibody; Plasminogen-binding protein antibody; PPH antibody; Tau crystallin antibody Product Type:Polyclonal Antibody Immunogen Species:Homo sapiens () UniProt ID:P06733 Immunogen:Fusion protein of ENO1 Raised in:Rabbit Reactivity:, Mouse, Rat Tested Applications:ELISA, WB, IHC; ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200 Background:This gene encodes alpha-enolase, one of three enolase isoenzymes found in mammals. Each isoenzyme is a homodimer composed of 2 alpha, 2 gamma, or 2 beta subunits, and functions as a glycolytic enzyme. Alpha-enolase in addition, functions as a structural lens protein (tau-crystallin) in the monomeric form. Alternative splicing of this gene resµLts in a shorter isoform that has been shown to bind to the c-myc promoter and function as a tumor suppressor. Several pseudogenes have been identified, including one on the long arm of chromosome 1. Alpha-enolase has also been identified as an autoantigen in Hashimoto encephalopathy. Clonality:Polyclonal Isotype:IgG Purification Method:Antigen affinity purification Conjµgate:Non-conjµgated Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:ENO1 Research Areas:Epigenetics and Nuclear Signaling;Cancer;Metabolism;Signal transduction